NDUFA13 and hepatocellular carcinoma: Functional experiments proved that SATB2-AS1 dampened HCC cell proliferation and metastasis and expedited its apoptosis, thus inactivating the miR-3678-3p/GRIM-19/STAT3/HIF-1α pathway.